AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30

Authors: Kaiser, R Tremblay, PB Schmider, J Henneken, M Dettling, M Muller-Oerlinghausen, B Uebelhack, R Roots, I Brockmoller, J
Citation: R. Kaiser et al., Serotonin transporter polymorphisms: no association with response to antipsychotic treatment, but associations with the schizoparanoid and residual subtypes of schizophrenia, MOL PSYCHI, 6(2), 2001, pp. 179-185

Authors: Schaub, RT Berghoefer, A Muller-Oerlinghausen, B
Citation: Rt. Schaub et al., What do patients in a lithium outpatient clinic know about lithium therapy?, J PSYCH NEU, 26(4), 2001, pp. 319-324

Authors: Zaninelli, R Bauer, M Jobert, M Muller-Oerlinghausen, B
Citation: R. Zaninelli et al., Changes in quantitatively assessed tremor during treatment of major depression with lithium augmented by paroxetine or amitriptyline, J CL PSYCH, 21(2), 2001, pp. 190-198

Authors: Ahrens, B Muller-Oerlinghausen, B
Citation: B. Ahrens et B. Muller-oerlinghausen, Does lithium exert an independent antisuicidal effect?, PHARMACOPS, 34(4), 2001, pp. 132-136

Authors: Bschor, T Canata, B Muller-Oerlinghausen, B Bauer, M
Citation: T. Bschor et al., Predictors of response to lithium augmentation in tricyclic antidepressant-resistant depression, J AFFECT D, 64(2-3), 2001, pp. 261-265

Authors: Bschor, T Muller-Oerlinghausen, B Ulrich, G
Citation: T. Bschor et al., Decreased level of EEG-vigilance in acute mania as a possible predictor for a rapid effect of methylphenidate: A case study, CLIN ELECTR, 32(1), 2001, pp. 36-39

Authors: Bauer, M Bschor, T Kunz, D Berghofer, A Strohle, A Muller-Oerlinghausen, B
Citation: M. Bauer et al., Lithium discontinuation: Uncovering latent bipolar disorder? Dr. Bauer andcolleagues reply, AM J PSYCHI, 158(8), 2001, pp. 1338-1339

Authors: Dettling, M Sachse, C Brockmoller, J Schley, J Muller-Oerlinghausen, B Pickersgill, I Rolfs, A Schaub, RT Schmider, J
Citation: M. Dettling et al., Long-term therapeutic drug monitoring of clozapine and metabolites in psychiatric in- and outpatients, PSYCHOPHAR, 152(1), 2000, pp. 80-86

Authors: Kaiser, R Konneker, M Henneken, M Dettling, M Muller-Oerlinghausen, B Roots, I Brockmoller, J
Citation: R. Kaiser et al., Dopamine D4 receptor 48-bp repeat polymorphism: no association with response to antipsychotic treatment, but association with catatonic schizophrenia, MOL PSYCHI, 5(4), 2000, pp. 418-424

Authors: Duffy, A Turecki, G Grof, P Cavazzoni, P Grof, E Joober, R Ahrens, B Berghofer, A Muller-Oerlinghausen, B Dvorakova, M Libigerova, E Vojtechovsky, M Zvolsky, P Nilsson, A Licht, RW Rasmussen, NA Schou, M Vestergaard, P Holzinger, A Schumann, C Thau, K Robertson, C Rouleau, GA Alda, M
Citation: A. Duffy et al., Association and linkage studies of candidate genes involved in GABAergic neurotransmission in lithium-responsive bipolar disorder, J PSYCH NEU, 25(4), 2000, pp. 353-358

Authors: Berghofer, A Muller-Oerlinghausen, B
Citation: A. Berghofer et B. Muller-oerlinghausen, Is there a loss of efficacy of lithium in patients treated for over 20 years?, NEUROPSYCHB, 42, 2000, pp. 46-49

Authors: Muller-Oerlinghausen, B Retzow, A Henn, FA Giedke, H Walden, J
Citation: B. Muller-oerlinghausen et al., Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: A prospective, randomized, double-blind, placebo-controlled, multicenter study, J CL PSYCH, 20(2), 2000, pp. 195-203

Authors: Dettling, M Sachse, C Muller-Oerlinghausen, B Roots, I Brockmoller, J Rolfs, A Cascorbi, I
Citation: M. Dettling et al., Clozapine-induced agranulocytosis and hereditary polymorphisms of clozapine metabolizing enzymes: No association with myeloperoxidase and cytochrome P450206, PHARMACOPS, 33(6), 2000, pp. 218-220

Authors: Franke, L Uebelhack, R Muller-Oerlinghausen, B
Citation: L. Franke et al., Platelet SHT and bipolar depressed patients, J AFFECT D, 60(2), 2000, pp. 141-142

Authors: Turecki, G Alda, M Grof, P Joober, R Lafreniere, R Cavazzoni, P Duffy, A Grof, E Ahrens, B Berghofer, A Muller-Oerlinghausen, B Dvorkova, M Libigerova, E Vojtechovsky, M Zvolsky, P Nilsson, A Prochazka, H Licht, RW Rasmussen, NA Schou, M Vestergaard, P Holzinger, A Schumann, C Thau, K Rouleau, GA
Citation: G. Turecki et al., Polyglutamine coding genes in bipolar disorder: lack of association with selected candidate loci, J AFFECT D, 58(1), 2000, pp. 63-68

Authors: Alda, M Turecki, G Grof, P Cavazzoni, P Duffy, A Grof, E Ahrens, B Berghofer, A Muller-Oerlinghausen, B Dvorakova, M Libigerova, E Vojtechovsky, M Zvolsky, P Joober, R Nilsson, A Prochazka, H Licht, RW Rasmussen, NA Schou, M Vestergaard, P Holzinger, A Schumann, C Thau, K Rouleau, GA
Citation: M. Alda et al., Association and linkage studies of CRH and PENK genes in bipolar disorder:A collaborative IGSLI study, AM J MED G, 96(2), 2000, pp. 178-181

Authors: Franke, L Schewe, HJ Muller, B Campman, V Kitzrow, W Uebelhack, R Berghofer, A Muller-Oerlinghausen, B
Citation: L. Franke et al., Serotonergic platelet variables in unmedicated patients suffering from major depression and healthy subjects - Relationship between 5HT content and 5HT uptake, LIFE SCI, 67(3), 2000, pp. 301-315

Authors: Muller-Oerlinghausen, B
Citation: B. Muller-oerlinghausen, Does effective lithium prophylaxis result in a symptom-free state of manic-depressive illness? Some thoughts on the fine-tuning of mood stabilization, COMP PSYCHI, 41(2), 2000, pp. 26-31

Authors: Bauer, M Bschor, T Kunz, D Berghofer, A Strohle, A Muller-Oerlinghausen, B
Citation: M. Bauer et al., Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression, AM J PSYCHI, 157(9), 2000, pp. 1429-1435

Authors: Turecki, G Alda, M Grof, P Joober, R Cavazzoni, P Duffy, A Grof, E Ahrens, B Berghofer, A Muller-Oerlinghausen, B Dvorakova, M Libigerova, E Vojtechovsky, M Zvolsky, P Nilsson, A Prochazka, H Licht, RW Rasmussen, NA Schou, M Vestergaard, P Holzinger, A Schumann, C Thau, K Rouleau, GA
Citation: G. Turecki et al., Polyglutamine tracts: no evidence of a major role in bipolar disorder, MOL PSYCHI, 4(3), 1999, pp. 220-221

Authors: Muller-Oerlinghausen, B
Citation: B. Muller-oerlinghausen, Drug interactions with lithium - A guide for clinicians, CNS DRUGS, 11(1), 1999, pp. 41-48

Authors: Bauer, M Zaninelli, R Muller-Oerlinghausen, B Meister, W
Citation: M. Bauer et al., Paroxetine and amitriptyline augmentation of lithium in the treatment of major depression: a double-blind study, J CL PSYCH, 19(2), 1999, pp. 164-171

Authors: Ferszt, R Kuhl, KP Bode, L Severus, EW Winzer, B Berghofer, A Beelitz, G Brodhun, B Muller-Oerlinghausen, B Ludwig, H
Citation: R. Ferszt et al., Amantadine revisited: An open trial of amantadinesulfate treatment in chronically depressed patients with Borna disease virus infection, PHARMACOPS, 32(4), 1999, pp. 142-147

Authors: Dettling, M Cascorbi, I Hellweg, R Deicke, U Weise, L Muller-Oerlinghausen, B
Citation: M. Dettling et al., Genetic determinants of drug-induced agranulocytosis: Potential risk of olanzapine?, PHARMACOPS, 32(3), 1999, pp. 110-112

Authors: Schumann, C Lenz, G Berghofer, A Muller-Oerlinghausen, B
Citation: C. Schumann et al., Non-adherence with long-term prophylaxis: a 6-year naturalistic follow-up study of affectively ill patients, PSYCHIAT R, 89(3), 1999, pp. 247-257
Risultati: 1-25 | 26-30